Why the study?
Does long-term minoxidil treatment reduce the need for beta-blockade in patients with severe hypertension?
Does long-term minoxidil treatment reduce the need for beta-blockade in patients with severe hypertension?
Long-term minoxidil treatment in severe hypertension may reduce or eliminate the need for concomitant beta-blockade.
Answers are grounded in this paper and cite their sources.
May support beta-blocker sparing with minoxidil in severe hypertension; leaves open long-term efficacy and safety.
Sequential changes in plasma renin activity and urinary aldosterone and noradrenaline were assessed in eight patients with severe hypertension after minoxidil had been added to their treatment. Doses of 2.5--27.5 (mean 12.5) mg/day reduced the mean blood pressure from 166/113 +/-6/2 mm Hg to 124/88+/-4/2 mm Hg in one week. Plasma renin activity and urinary aldosterone and noradrenaline increased twofold to threefold initially but returned to baseline values within two to three weeks and remained unchanged during a mean follow-up of 5.1 months. Beta-blocking drugs were then withdrawn slowly in six patients without adverse effects, though blood pressure and heart rate increased in three patients, who required minimal doses of beta-blockers. Plasma renin activity and urinary aldosterone and noradrenaline did not change significantly after beta-blockade had been stopped. We conclude that the need for beta-blockade is greatly reduced with long-term minoxidil treatment and that it may be unnecessary in some patients.
No takes yet. Share an insight, caveat, or question.
Brunner et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: